Viewing Study NCT01983735


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2025-12-25 @ 8:15 PM
Study NCT ID: NCT01983735
Status: UNKNOWN
Last Update Posted: 2013-11-14
First Post: 2013-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
Sponsor: Chong Kun Dang Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module